Abstract
Familial partial lipodystrophy type 2 (FPLD2) is an autosomal dominant disorder caused by mutations in LMNA gene, which is characterized by adolescent onset selective subcutaneous fat loss with metabolic abnormalities such as insulin resistance. Severe insulin resistance can cause acanthosis nigricans, pseudoacromegaly, ovarian dysfunction, glucose, and lipid metabolism disorders. Therefore, it is often misdiagnosed as metabolic syndrome, type 2 diabetes, polycystic ovary syndrome, acromegaly, and Cushing′s syndrome. Through the analysis of the diagnosis and treatment of a case of FPLD2 with acromegaly, and the importance of tracing the origin of the disease is emphasized and also does the role of genetic testing in diagnosis. It suggests that clinicians should pay attention to the fat distribution of those similar patients, and make diagnosis and treatment timely. Key words: Lipodystrophy; LMNA gene; Fat distribution; Acromegaloidism
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
